Can we create a valid treatment algorithm for patients with drug resistant overactive bladder (OAB) syndrome or detrusor overactivity (DO)? Results from a think tank (ICI-RS 2015)

Apostolos Apostolidis*, Marcio Augusto Averbeck, Arun Sahai, Sajjad Rahnama'i, Ralf Anding, Dudley Robinson, Stavros Gravas, Roger Dmochowski

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)882-893
Number of pages12
JournalNeurourology and Urodynamics
Volume36
Issue number4
DOIs
Publication statusPublished - Apr 2017
EventICI-RS Meeting - Bristol
Duration: 1 Jun 2015 → …

Keywords

  • anticholinegics
  • antimuscarinics
  • augmentation cystoplasty
  • botulinum (neuro)toxin
  • detrusor myectomy
  • drug resistant
  • guidelines
  • management
  • neuromodulation
  • overactive bladder
  • percutaneous tibial nerve stimulation
  • refractory
  • treatment
  • urinary diversion
  • TIBIAL NERVE-STIMULATION
  • URINARY URGE INCONTINENCE
  • PLACEBO-CONTROLLED TRIAL
  • BOTULINUM-TOXIN-A
  • QUALITY-OF-LIFE
  • RANDOMIZED CLINICAL-TRIAL
  • CORD-INJURY PATIENTS
  • SACRAL NEUROMODULATION
  • DOUBLE-BLIND
  • AUGMENTATION CYSTOPLASTY

Cite this